Active substance:
- Canarypox virus, strain vCP3011, expressing haemagglutinin gene of Influenza A virus subtype H3N8 (A/equine/Richmond/1/2007), Live
- Canarypox virus, strain vCP2242, expressing haemagglutinin gene of Influenza A virus subtype H3N8 (A/equine/Ohio/03), Live
Route of administration:
-
Intramuscular use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Horse